Litcius/Paper detail

Pharmacological and genetic inhibition of ARG2 in CXCR2<sup>Hi</sup> myeloid-derived suppressor cells combats sepsis-induced lymphopenia

Qiuyue Long, Shixu Song, Jiwei Li, Jialing Gan, Shuoqi Yang, Boyu Li, Hongli Ye, Binghan Zheng, Fangfang Wu, Zhichen Yu, Jing Wu, Linyu Ding, Mingzheng Jiang, Xiaoyi Hu, Zhancheng Gao, Yali Zheng

2025Theranostics8 citationsDOIOpen Access PDF

Abstract

MDSC-derived ARG2 as a promising target of immune enhancement therapy in sepsis.

Topics & Concepts

SuppressorSepsisMyeloid-derived Suppressor CellImmunologyMyeloidCXC chemokine receptorsCancer researchBiologyMedicinePharmacologyChemistryInflammationGeneticsChemokineGeneChemokine receptorInflammation biomarkers and pathwaysSepsis Diagnosis and TreatmentAmoebic Infections and Treatments
Pharmacological and genetic inhibition of ARG2 in CXCR2<sup>Hi</sup> myeloid-derived suppressor cells combats sepsis-induced lymphopenia | Litcius